Cargando…

ERAPSO: Revealing the High Burden of Obesity in German Psoriasis Patients

INTRODUCTION: Plaque psoriasis is a chronic, systemic-inflammatory disease characterized by skin erythema, plaques and scaling, and is associated with different comorbidities like psoriatic arthritis, obesity, and cardiometabolic diseases. Obesity aggravates cardiovascular risk in psoriasis patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwarz, Peter E. H., Pinter, Andreas, Melzer, Nima, Barteczek, Philipp, Reinhardt, Maximilian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704194/ https://www.ncbi.nlm.nih.gov/pubmed/31297711 http://dx.doi.org/10.1007/s13555-019-0314-1

Ejemplares similares

Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial
por: Pinter, Andreas, et al.
Publicado: (2021)

Hidradenitis Suppurativa and Concurrent Psoriasis: Comparison of Epidemiology, Comorbidity Profiles, and Risk Factors
por: Pinter, Andreas, et al.
Publicado: (2020)

Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients
por: Gerdes, S., et al.
Publicado: (2019)

Impact of psoriasis disease activity and other risk factors on serum urate levels in patients with psoriasis and psoriatic arthritis—a post-hoc analysis of pooled data from three phase 3 trials with secukinumab
por: Dehlin, Mats, et al.
Publicado: (2021)

Clinical Course and Characteristics of Generalized Pustular Psoriasis
por: Choon, Siew Eng, et al.
Publicado: (2022)

Efficacy and Safety of Secukinumab in Elderly Subjects with Moderate to Severe Plaque Psoriasis: A Pooled Analysis of Phase III Studies
por: Körber, Andreas, et al.
Publicado: (2018)

Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest
por: Reich, K., et al.
Publicado: (2015)

German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)
por: Nast, A., et al.
Publicado: (2007)

The burden of psoriasis: a call for awareness
por: EClinicalMedicine
Publicado: (2021)

German Mobile Apps for Patients With Psoriasis: Systematic Search and Evaluation
por: Lull, Christian, et al.
Publicado: (2022)

Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey
por: Pinter, Andreas, et al.
Publicado: (2020)

Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review
por: Pinter, Andreas, et al.
Publicado: (2019)

The burden of psoriasis in patients with early psoriatic arthritis
por: Kasiem, Fazira R, et al.
Publicado: (2021)

The Societal Economic Impact of Secukinumab in First-Line Treatment of Moderate to Severe Plaque Psoriasis in Germany: An Open-Cohort Simulation
por: Seddik, Ahmed H., et al.
Publicado: (2021)

Long-Term Effects of a Video-Based Smartphone App (“VIDEA Bewegt”) to Increase the Physical Activity of German Adults: A Single-Armed Observational Follow-Up Study
por: Reinhardt, Gesine, et al.
Publicado: (2021)

Video-based smartphone app (‘VIDEA bewegt’) for physical activity support in German adults: a study protocol for a single-armed observational study
por: Fischer, Tillmann, et al.
Publicado: (2020)

Psoriasis Causes Significant Economic Burden to Patients
por: Mustonen, A., et al.
Publicado: (2014)

Economic Burden of Comorbidities in Patients with Psoriasis in the USA
por: Wu, Jashin J., et al.
Publicado: (2022)

Economic Burden of Obesity: A Systematic Literature Review
por: Tremmel, Maximilian, et al.
Publicado: (2017)

Subjective burden and perspectives of German healthcare workers during the COVID-19 pandemic
por: Kramer, Victoria, et al.
Publicado: (2020)

Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature
por: Pinter, Andreas, et al.
Publicado: (2018)

Psychosocial Burden of Psoriasis: A Systematic Literature Review of Depression Among Patients with Psoriasis
por: Luna, Paula C., et al.
Publicado: (2023)

Psoriasis: Obesity and Fatty Acids
por: Kunz, Manfred, et al.
Publicado: (2019)

Update on Obesity in Psoriasis Patients
por: Vata, Dan, et al.
Publicado: (2023)

Burden of Herpes Zoster in Adult Patients with Underlying Conditions: Analysis of German Claims Data, 2007–2018
por: Batram, Manuel, et al.
Publicado: (2021)

Novel anti‐inflammatory therapies to reduce cardiovascular burden of psoriasis
por: Piros, Éva Anna, et al.
Publicado: (2021)

A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
por: Kirkham, Bruce W., et al.
Publicado: (2023)

Burden of chronic urticaria relative to psoriasis in five European countries
por: Balp, M.M., et al.
Publicado: (2017)

The German National Program on Psoriasis Health Care 2005–2015: results and experiences
por: Augustin, M., et al.
Publicado: (2016)

Psoriasis is Associated with a High Comedication Burden: A Population Based Register Study
por: Duvetorp, Albert, et al.
Publicado: (2020)

Disease burden of methylmercury in the German birth cohort 2014
por: Lackner, Julia, et al.
Publicado: (2018)

An anticholinergic burden score for German prescribers: score development
por: Kiesel, Esther Katharina, et al.
Publicado: (2018)

Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis
por: Ezzedine, Khaled, et al.
Publicado: (2020)

The length of stay and inpatient burden in inpatients with different psoriasis subtypes
por: Wang, Qiaolin, et al.
Publicado: (2022)

Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis
por: Feldman, Steven R., et al.
Publicado: (2015)

Burden of Herpes Zoster Among Patients with Psoriasis in the United States
por: Singer, David, et al.
Publicado: (2023)

Self-management of psoriasis vulgaris treatment burden: A Review
por: Zhu, Dan, et al.
Publicado: (2023)

IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE)
por: Eyerich, Kilian, et al.
Publicado: (2021)

Redistributing ill-defined deaths in the German Burden of Disease study BURDEN 2020: Annelene Wengler
por: Wengler, A, et al.
Publicado: (2022)

Is polypharmacy an increasing burden in chronic kidney disease? The German experience
por: Parker, Kathrine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ipms1ue1bepf670prro7b4om8l